Håkan Mellstedt

Filings by Håkan Mellstedt span 2 companies, the busiest being Kancera AB and Kancera. In total, 10 filings cover trades dated from 30 May 2017 to 22 May 2018.

In open-market terms, that means 4 purchases worth €15k on one side and 6 sales worth €2,668 on the other. On balance, insiders were net buyers of €12k. Unlike grants, an open-market purchase is paid for by the insider, at the market price. In 2018 alone, the filings show 3 purchases and 6 sales.

In size, the median ticket on the buying side is €1,493. 1 out of 4 purchases came within 30 days of a purchase by at least one other insider of the same company. Such overlaps are known as a cluster signal: distinct people reaching the same decision at about the same time.

On 24 May 2018 came the latest disclosure, an open-market purchase for €57 in Kancera. The median gap between a trade and its publication by Finansinspektionen is 1 day. For comparison, MAR article 19 gives managers three business days to notify a trade. Selling is not necessarily a view on the stock: liquidity needs and diversification are common motives. This summary is built from Finansinspektionen disclosures alone and does not predict where the share price will go.